Business Context and Reporting Period
This Form 8-K is filed by Oculus Innovative Sciences, Inc. (not Sonoma Pharmaceuticals, Inc., as indicated in the metadata) on February 7, 2008. The report serves to announce the financial results for the company's third fiscal quarter ended December 31, 2007. The full details of these results are contained in a press release furnished as Exhibit 99.1.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the attached press release (Exhibit 99.1), which is not included in the source text.
Material Changes
The filing does not provide specific data regarding material changes versus the prior comparable period. It solely references the issuance of the press release containing the third-quarter results.
Guidance, Outlook, and Risks
The text does not include management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. The document functions as a notification that the press release containing this information has been issued.
Investor Verification Checklist
- Verify the correct registrant name is Oculus Innovative Sciences, Inc., not Sonoma Pharmaceuticals, Inc.
- Locate and review Exhibit 99.1 (the press release dated February 7, 2008) to obtain actual financial figures for the quarter ended December 31, 2007.
- Confirm the specific revenue and net income figures for the third fiscal quarter 2007 from the external press release.
- Check for any updated guidance or operational milestones mentioned in the full press release text.